Dorda, working with Linklaters, Kromann Reumert, and Wilson Sonsini Goodrich & Rosati, has advised Novo Holdings on its acquisition of Single Use Support. E+H advised the Single Use Support founders and Binder Groesswang advised Danaher on the sale side. Kirkland & Ellis reportedly advised Danaher as well.
Novo Holdings is a holding and investment entity of the Danish Novo Nordisk Foundation.
Single Use Support is an Austrian provider of modern technology solutions for pharmaceutical production processes.
Danaher designs, manufactures, and markets medical, industrial, and commercial products and services.
According to Dorda, "with the acquisition of a majority of around 60% of the shares in Single Use Support, which is still subject to antitrust approval, Novo Holdings is expanding its rapidly growing Life Science Tools & Diagnostics portfolio, thus gaining a foothold in the DACH region, an important center for life sciences."
The Dorda team included Partners Martin Brodey, Bernhard Rieder, Tibor Varga, Heinrich Kuehnert, Bernhard Mueller, Magdalena Brandstetter, Francine Brogyanyi, Andreas Seling, Christian Ritschka, Nino Tlapak, and Veit Oehlberger, Counsel Magdalena Nitsche, Principal Associates Patricia Backhausen, Alexandra Ciarnau, Safiye Unuvar, Lorenz Wicho, Florina Thenmayer, Georg Durstberger, Julia Landskron, and Clemens Burian-Kerbl, and Associates Aleksandra Huebl-Langer, Mirko Marjanovic, Stefanie Dirnbauer, Valentina Possegger, Philipp Proske, Noah Hofer, Laura Colloredo-Mannsfeld, Felix Zopf, and Silvia Hanschur.
The E+H team included Partners Peter Winkler, Philipp Schrader, Clemens Lanschuetzer, Dominik Juster, Jana Eichmeyer, Helmut Liebel, Florian Sagmeister, Marcus Benes, Dieter Thalhammer, and Judith Feldner, Attorneys at Law Helena Neuner, Titus Kahr, and William Redl, and Associates Yvonne Wohlmuth, Alexander Moser, Markus Feneberger, Alexandra Stadlober, Laura-Sophie Polzhofer, Franziska Egger, Gabriele Kaiser, Iris Hermetter, and Yvonne Handler.
The Binder Groesswang team was led by Partner Thomas Schirmer.
